Skip to main content
SpringerLink
Log in

Polypharmacy in Psychiatry Practice, Volume I

Multiple Medication Use Strategies

  • Book
  • © 2013

Overview

Editors:
  1. Michael S. Ritsner

    1. Sha'ar Menashe Mental Health Center, Hadera, Israel

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • This is the first comprehensive volume regarding the multiple medication use in psychiatry
  • Preclinical and clinical investigation of the multiple medication use in psychiatry
  • Evidence-based monitoring important research developments in this field

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (11 chapters)

  1. Front Matter

    Pages i-xvii
    Download chapter PDF

  2. Polypharmacy Treatment Strategies

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Multiple Psychiatric Medications Use in Psychiatry: How Rational Can It Be?

      • Ahsan Y. Khan, Sheldon H. Preskorn
      Pages 3-24

    3. Receptor Binding Targets for Antipsychotic Efficacy

      • Maureen M. Grainger, Rebecca Ahlbrand, Paul S. Horn, Neil M. Richtand
      Pages 25-43

    4. Drug Interactions and Polypharmacy

      • Jessica L. Gören, Ashley Tewksbury
      Pages 45-74

    5. Preclinical and Clinical Investigation of Antipsychotic Polypharmacy: What Is the Evidence?

      • Dimitrios Kontis, Eirini Theochari
      Pages 75-105

    6. Should High Dose or Very Long-Term Antipsychotic Monotherapy Be Considered Before Antipsychotic Polypharmacy?

      • Stephen M. Stahl, Debbi A. Morrissette
      Pages 107-125

    7. Multiple Medication Use of Neuropsychiatry in Forensic Psychiatry: Findings from the Central State Forensic Psychiatric Hospital of Saxony-Anhalt

      • Joachim G. Witzel
      Pages 127-134

  3. Augmentation Strategies

    1. Front Matter

      Pages 135-135
      Download chapter PDF

    2. Antipsychotic Treatment Within a Naturalistic Trial—How Are We Treating Schizophrenia Patients in the “Real-World”?

      • Rebecca Schennach, Michael Obermeier, Florian Seemüller, Daniela Krause, Richard Musil, Ilja Spellmann et al.
      Pages 137-156

    3. A Multi-Target Drug Treatment in Schizophrenia and Schizoaffective Disorder Using Adjunctive Agents with Non-D2 Mechanisms of Action

      • Michael S. Ritsner
      Pages 157-210

    4. Antidepressants in Schizophrenia: A Place for Them?

      • Viacheslav Terevnikov, Grigori Joffe
      Pages 211-231

    5. Stress Sensitization and Anticonvulsant Medication in Psychiatric Patients

      • Petr Bob
      Pages 233-242

    6. Multiple Medication Use in Somatic Symptom Disorders: From Augmentation to Diminution Strategies

      • Adrian P. Mundt
      Pages 243-254

  4. Back Matter

    Pages 255-287
    Download chapter PDF
Back to top

Keywords

About this book

Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume set is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.

Reviews

From the reviews:

“This is part of a two-volume set that is the first comprehensive, clinically oriented reference that looks at the evidence regarding the use of multiple medications in the treatment of a variety of mental illnesses. … should be read by anyone involved in the pharmacological management of psychiatric illnesses.” (Michael Easton, Doody’s Book Reviews, July, 2013)

Editors and Affiliations

  • Sha'ar Menashe Mental Health Center, Hadera, Israel

    Michael S. Ritsner

Bibliographic Information

  • Book Title: Polypharmacy in Psychiatry Practice, Volume I

  • Book Subtitle: Multiple Medication Use Strategies

  • Editors: Michael S. Ritsner

  • DOI: https://doi.org/10.1007/978-94-007-5805-6

  • Publisher: Springer Dordrecht

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer Science+Business Media Dordrecht 2013

  • Hardcover ISBN: 978-94-007-5804-9Published: 28 February 2013

  • Softcover ISBN: 978-94-017-8512-9Published: 08 February 2015

  • eBook ISBN: 978-94-007-5805-6Published: 15 February 2013

  • Edition Number: 1

  • Number of Pages: XVII, 287

  • Number of Illustrations: 3 b/w illustrations, 28 illustrations in colour

  • Topics: Biomedicine general, Psychiatry, Pharmacy, Clinical Psychology, Medical Education, Psychopharmacology

Publish with us

Policies and ethics

Back to top

Search

Navigation